X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (118) 118
Publication (31) 31
Book / eBook (3) 3
Book Review (3) 3
Dissertation (2) 2
Book Chapter (1) 1
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (58) 58
index medicus (45) 45
male (35) 35
female (34) 34
adult (30) 30
infectious diseases (22) 22
hiv (19) 19
hiv infections - drug therapy (19) 19
middle aged (19) 19
immunology (18) 18
pharmacology & pharmacy (17) 17
medical and health sciences (14) 14
medicin och hälsovetenskap (14) 14
article (13) 13
research (13) 13
aged (12) 12
anti-hiv agents - therapeutic use (12) 12
genome-wide association study (11) 11
microbiology (11) 11
polymorphism, single nucleotide (11) 11
aids (10) 10
drug interactions (10) 10
adolescent (9) 9
human immunodeficiency virus--hiv (9) 9
pregnancy (9) 9
clinical medicine (8) 8
genetics (8) 8
klinisk medicin (8) 8
pharmacokinetics (8) 8
risk (8) 8
antiretroviral therapy (7) 7
cohort studies (7) 7
epidemiology (7) 7
genetics & heredity (7) 7
human-immunodeficiency-virus (7) 7
infections (7) 7
mortality (7) 7
multidisciplinary sciences (7) 7
mutation (7) 7
pharmacology (7) 7
risk factors (7) 7
aids-related opportunistic infections - drug therapy (6) 6
care and treatment (6) 6
drug therapy (6) 6
genetic aspects (6) 6
genomes (6) 6
genotype (6) 6
hiv infection (6) 6
hiv infections - complications (6) 6
hiv infections - virology (6) 6
studies (6) 6
viral load (6) 6
viruses (6) 6
young adult (6) 6
abridged index medicus (5) 5
aids-related opportunistic infections - prevention & control (5) 5
analysis (5) 5
animals (5) 5
antiretroviral drugs (5) 5
biological sciences (5) 5
cardiovascular diseases (5) 5
cd4 lymphocyte count (5) 5
diagnosis (5) 5
disease (5) 5
genetic variation (5) 5
genome-wide association (5) 5
hiv infections - immunology (5) 5
metaanalysis (5) 5
natural sciences (5) 5
naturvetenskap (5) 5
phenotype (5) 5
protease inhibitors (5) 5
resistance (5) 5
south africa (5) 5
virology (5) 5
adults (4) 4
aged, 80 and over (4) 4
aids/hiv (4) 4
anti-hiv agents - adverse effects (4) 4
child (4) 4
development and progression (4) 4
dolutegravir (4) 4
dosage (4) 4
efavirenz (4) 4
european continental ancestry group - genetics (4) 4
gene expression (4) 4
gene-expression (4) 4
genetic predisposition to disease (4) 4
genomics (4) 4
human immunodeficiency virus (4) 4
insulin (4) 4
meta-analysis (4) 4
practice guidelines as topic (4) 4
pregnancy complications, infectious - drug therapy (4) 4
proteins (4) 4
raltegravir (4) 4
recommendations (4) 4
research article (4) 4
ritonavir - therapeutic use (4) 4
safety (4) 4
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Clinical Infectious Diseases, ISSN 1058-4838, 2014, Volume 58, Issue 9, pp. 1308 - 1311
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 07/2019
Abstract Eight-day inpatient directly observed therapy confirmed nonadherence as the major cause of virologic failure for 9 (45%) of 20 highly... 
Journal Article
Annals of Internal Medicine, ISSN 0003-4819, 09/2002, Volume 137, Issue 5 Part 2, pp. 381 - 433
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 04/2016, Volume 62, Issue 8, p. 1036
  The current study was conducted to determine if efavirenz (EFV) or atazanavir/ritonavir (ATV/r)-based combination antiretroviral therapy (cART) impacted... 
Prescription drugs | Antiretroviral drugs | Human immunodeficiency virus--HIV | Pharmacology | Kinetics
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 04/2016, Volume 62, Issue 8, pp. 1036 - 1036
The current study was conducted to determine if efavirenz (EFV) or atazanavir/ritonavir (ATV/r)-based combination antiretroviral therapy (cART) impacted... 
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 04/2016, Volume 62, Issue 8, pp. 1036 - 1042
The current study was conducted to determine if efavirenz (EFV) or atazanavir/ritonavir (ATV/r)-based combination antiretroviral therapy (cART) impacted... 
Pneumocystis jiroveci pneumonia | toxoplasma encephalitis | atovaquone | drug interaction | efavirenz | Encephalitis - prevention & control | Atovaquone - therapeutic use | Anti-Infective Agents - blood | Humans | Middle Aged | Pneumonia, Pneumocystis - prevention & control | Atovaquone - pharmacokinetics | Male | Atazanavir Sulfate - adverse effects | Toxoplasmosis, Cerebral - drug therapy | Toxoplasmosis, Cerebral - prevention & control | Reverse Transcriptase Inhibitors - adverse effects | Young Adult | Drug Therapy, Combination - adverse effects | Drug Interactions | Ritonavir - adverse effects | Encephalitis - drug therapy | Ritonavir - therapeutic use | Adult | Anti-HIV Agents - therapeutic use | Female | Reverse Transcriptase Inhibitors - therapeutic use | Atovaquone - blood | HIV Protease Inhibitors - adverse effects | Pneumonia, Pneumocystis - drug therapy | Administration, Oral | AIDS-Related Opportunistic Infections - drug therapy | Anti-Infective Agents - therapeutic use | Benzoxazines - adverse effects | HIV Protease Inhibitors - therapeutic use | Benzoxazines - therapeutic use | Atazanavir Sulfate - therapeutic use | Anti-Infective Agents - pharmacokinetics | Adolescent | HIV Infections - drug therapy | Aged | Atazanavir | Atovaquone | Analysis | Dosage and administration | Chemical properties | Research | HIV (Viruses) | Efavirenz | HIV | AIDS
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 07/2018, Volume 67, Issue 2, p. 193
Background Once-weekly isoniazid and rifapentine for 3 months is a treatment option in persons with human immunodeficiency virus and latent tuberculosis... 
C-reactive protein | Cytokines | Toxicity | Drug interactions | Antibodies | Viruses | Pyridoxine | Pharmacology | Proteins | Confidence intervals | Side effects | Tuberculosis | Antiretroviral agents | Human immunodeficiency virus--HIV | CXCL10 protein | Drug interaction | Interferon | Isoniazid
Journal Article
Journal Article
AIDS Research and Human Retroviruses, ISSN 0889-2229, 08/2018, Volume 34, Issue 8, pp. 68 - 684
The presence of non-B HIV subtypes in the USA has been documented during the epidemic, although the timing of early introductions of different subtypes remains... 
Epidemiology
Journal Article
Journal Article
JAIDS Journal of Acquired Immune Deficiency Syndromes, ISSN 1525-4135, 07/2013, Volume 63, Issue 3, pp. 355 - 361
Journal Article
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 07/2019
Among 20 highly treatment experienced people with HIV with extensive antiretroviral drug resistance and high levels of self-reported adherence, an inpatient... 
Journal Article
Journal of Acquired Immune Deficiency Syndromes, ISSN 1525-4135, 07/2013, Volume 63, Issue 3, p. 355
  To identify an alternative inhaled corticosteroid to fluticasone propionate that can be safely coadministered with HIV protease inhibitors, the safety and... 
Antiretroviral drugs | Protease inhibitors | Pharmacology | Drug therapy | Drug dosages
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.